Review
doi: 10.1159/000074623.
Cyclin-dependent kinase 5 in amyotrophic lateral sclerosis
Affiliations
- PMID: 14673208
- DOI: 10.1159/000074623
Item in Clipboard
Review
Cyclin-dependent kinase 5 in amyotrophic lateral sclerosis
Neurosignals.
2003 Sep-Oct.
Abstract
Amyotrophic lateral sclerosis is a neurological disorder that selectively affects motor neurons of brain and spinal cord. Emerging evidence indicates an involvement of the serine/threonine-cyclin-dependent kinase 5 (Cdk5) in the pathogenesis. Deregulation of Cdk5 by its truncated co-activators, p25 and p29, contributes to neurodegeneration by altering the phosphorylation state of cytosolic and cytoskeletal proteins and, possibly, through the induction of cell cycle regulators. The present paper reviews these findings and proposes new perspectives to decipher the mechanisms of neurodegeneration in amyotrophic lateral sclerosis induced by Cdk5.
Copyright 2003 S. Karger AG, Basel
Similar articles
-
Cyclin-dependent kinase 5 in Lewy body-like inclusions in anterior horn cells of a patient with sporadic amyotrophic lateral sclerosis.Neurology. 1997 Jan;48(1):267-70. doi: 10.1212/wnl.48.1.267. Neurology. 1997. PMID: 9008532
-
Cycling at the interface between neurodevelopment and neurodegeneration.Cell Death Differ. 2002 Dec;9(12):1294-306. doi: 10.1038/sj.cdd.4401108. Cell Death Differ. 2002. PMID: 12478466 Review.
-
Cyclin-dependent kinase-5 (CDK5) and amyotrophic lateral sclerosis.Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):319-27. doi: 10.1080/146608200300079563. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000. PMID: 11464850 Review.
-
Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions.Neuron. 2001 Apr;30(1):135-47. doi: 10.1016/s0896-6273(01)00268-9. Neuron. 2001. PMID: 11343650
-
A decade of CDK5.Nat Rev Mol Cell Biol. 2001 Oct;2(10):749-59. doi: 10.1038/35096019. Nat Rev Mol Cell Biol. 2001. PMID: 11584302 Review.
Cited by
-
Study of the inhibition of cyclin-dependent kinases with roscovitine and indirubin-3'-oxime from molecular dynamics simulations.J Mol Model. 2007 Jan;13(1):79-89. doi: 10.1007/s00894-006-0127-x. Epub 2006 Jun 13. J Mol Model. 2007. PMID: 16770643
-
Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing.Bone Res. 2022 Apr 6;10(1):33. doi: 10.1038/s41413-022-00195-z. Bone Res. 2022. PMID: 35383146 Free PMC article.
-
Inhibition of Cdk5 Ameliorates Skeletal Bone Loss in Glucocorticoid-Treated Mice.Biomedicines. 2022 Feb 8;10(2):404. doi: 10.3390/biomedicines10020404. Biomedicines. 2022. PMID: 35203613 Free PMC article.
-
Mechanism of CDK5 activation revealed by steered molecular dynamics simulations and energy calculations.J Mol Model. 2010 Jun;16(6):1159-68. doi: 10.1007/s00894-009-0629-4. Epub 2009 Dec 15. J Mol Model. 2010. PMID: 20013135
-
Neuroprotective Mechanisms Mediated by CDK5 Inhibition.Curr Pharm Des. 2016;22(5):527-34. doi: 10.2174/1381612822666151124235028. Curr Pharm Des. 2016. PMID: 26601962 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
